缓激肽受体 (Bradykinin Receptor) 是细胞表面的 G 蛋白偶联受体 (GPCR) 家族成员。缓激肽受体有两种亚型,B1 和 B2。缓激肽受体介导的信号转导在维持心血管稳态、调节疼痛和炎症方面发挥着重要作用。两种受体都通过激活 G 蛋白传递细胞外信号。
缓激肽 B1 受体在健康组织中的表达水平非常低,但在休克或炎症等应激条件下会被诱导,而缓激肽 B2 受体则无处不在且呈组成性表达。缓激肽 B2 受体参与血管舒张、渗透调节、平滑肌收缩和伤害感受器激活。缓激肽 B1 受体和缓激肽 B2 受体已成为治疗靶点,因为它们与炎症性疾病、血管病变、神经病变、肥胖症、糖尿病和癌症有关。B1R 和 B2R 在疾病中可发挥两种不同的作用。激动剂和拮抗剂已被评估为治疗剂。
Bradykinin receptors are cell surface, G protein-coupled receptor (GPCR) family members. There are two subtypes of bradykinin receptors, B1 and B2. Bradykinin receptor-mediated signal transductions play a significant role in maintaining cardiovascular homeostasis, regulating pain and inflammation. Both receptors transduce extracellular signals through the activation of G-proteins.
Bradykinin B1 receptor is expressed at a very low level in healthy tissues, but is induced under stressful conditions such as shock or inflammation, whereas the bradykinin B2 receptor is ubiquitous and is constitutively expressed. Bradykinin B2 receptor is involved in vasodilation, osmoregulation, smooth muscle contraction, and nociceptor activation. Bradykinin B1 receptor and Bradykinin B2 receptor have emerged as therapeutic targets as they are implicated in inflammatory disease, vasculopathy, neuropathy, obesity, diabetes, and cancer. B1R and B2R can hold dichotomous roles in diseases. Agonists and antagonists have been evaluated as therapeutics.
Bradykinin (1-6) 是一种氨基截短的激肽肽,也是由羧肽酶 Y 切割形成的一种稳定的 Bradykinin 代谢物。
Bradykinin (1-7) 是一种由内肽酶切割 Bradykinin 形成的氨基截短激肽肽,也是 Bradykinin 的一种代谢物。
Bradykinin (2-9) 是一种由氨基肽酶 P 切割 Bradykinin 形成的氨基截短激肽肽,也是一种 Bradykinin 代谢物。
Bradykinin acetate 是一种有效的内皮依赖性血管扩张剂,可降低血压,同时可引起支气管和肠道非血管平滑肌收缩、增加血管通透性,并参与疼痛机制。
Bradykinin triacetate 是一种有效的内皮依赖性血管扩张剂,可降低血压,同时可引起支气管和肠道非血管平滑肌收缩、增加血管通透性,并参与疼痛机制。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号